Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET).

Graebe M, Pedersen SF, Borgwardt L, Højgaard L, Sillesen H, Kjaer A.

Eur J Vasc Endovasc Surg. 2009 Jun;37(6):714-21. doi: 10.1016/j.ejvs.2008.11.018. Epub 2008 Dec 27.

2.

Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease.

Stolzmann P, Subramanian S, Abdelbaky A, Maurovich-Horvat P, Scheffel H, Tawakol A, Hoffmann U.

Radiographics. 2011 Sep-Oct;31(5):1255-69. doi: 10.1148/rg.315115028. Review.

PMID:
21918043
3.

FDG PET/CT Imaging of Carotid Atherosclerosis.

Ali A, Tawakol A.

Neuroimaging Clin N Am. 2016 Feb;26(1):45-54. doi: 10.1016/j.nic.2015.09.004. Review.

PMID:
26610659
4.

Positron emission tomography of the vulnerable atherosclerotic plaque in man--a contemporary review.

Pedersen SF, Hag AM, Klausen TL, Ripa RS, Bodholdt RP, Kjaer A.

Clin Physiol Funct Imaging. 2014 Nov;34(6):413-25. doi: 10.1111/cpf.12105. Epub 2013 Dec 1. Review.

5.

Novel non-invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose-positron emission tomography.

Kai H.

Geriatr Gerontol Int. 2010 Jan;10(1):1-8. doi: 10.1111/j.1447-0594.2009.00564.x. Review.

PMID:
20102376
6.

FDG-PET imaging of atherosclerosis: Do we know what we see?

Sheikine Y, Akram K.

Atherosclerosis. 2010 Aug;211(2):371-80. doi: 10.1016/j.atherosclerosis.2010.01.002. Epub 2010 Feb 1. Review.

PMID:
20202637
7.

Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?

Hermann S, Starsichova A, Waschkau B, Kuhlmann M, Wenning C, Schober O, Schäfers M.

J Nucl Cardiol. 2012 Jun;19(3):609-17. doi: 10.1007/s12350-012-9553-6. Review.

PMID:
22477642
8.

F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques.

Kang WJ.

Korean J Radiol. 2015 Nov-Dec;16(6):1257-61. doi: 10.3348/kjr.2015.16.6.1257. Epub 2015 Oct 26. Review.

9.

Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries.

Chen W, Bural GG, Torigian DA, Rader DJ, Alavi A.

Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):144-51. doi: 10.1007/s00259-008-0947-2. Epub 2008 Nov 4. Review.

PMID:
18982324
10.

Vascular imaging with positron emission tomography.

Joshi F, Rosenbaum D, Bordes S, Rudd JH.

J Intern Med. 2011 Aug;270(2):99-109. doi: 10.1111/j.1365-2796.2011.02392.x. Epub 2011 May 18. Review.

11.

Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis.

Tahara N, Imaizumi T, Virmani R, Narula J.

J Nucl Med. 2009 Mar;50(3):331-4. doi: 10.2967/jnumed.108.060376. Epub 2009 Feb 17. Review.

12.

Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.

Rogers IS, Tawakol A.

Curr Cardiol Rep. 2011 Apr;13(2):138-44. doi: 10.1007/s11886-011-0168-3. Review.

PMID:
21274660
13.

Molecular imaging of the atherosclerotic plaque using positron emission tomography.

Toor IS, Dweck MR, Newby DE.

J R Coll Physicians Edinb. 2014;44(2):139-45. doi: 10.4997/JRCPE.2014.212. Review.

PMID:
24999778
14.

PET imaging of atherosclerosis.

Tarkin JM, Joshi FR, Rajani NK, Rudd JH.

Future Cardiol. 2015;11(1):115-31. doi: 10.2217/fca.14.55. Review.

PMID:
25606707
15.

Radionuclide imaging for the detection of inflammation in vulnerable plaques.

Davies JR, Rudd JH, Weissberg PL, Narula J.

J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C57-68. Review.

Supplemental Content

Support Center